Kanser olu\u015fumunda kritik bir fakt\u00f6r olarak h\u00fccre d\u00f6ng\u00fcs\u00fc s\u00fcresi, Toronto\u2019daki Sinai Health\u2019e ba\u011fl\u0131 Lunenfeld-Tanenbaum Ara\u015ft\u0131rma Enstit\u00fcs\u00fc\u2019nde yap\u0131lan \u00e7\u0131\u011f\u0131r a\u00e7\u0131c\u0131 bir ara\u015ft\u0131rmada ortaya kondu. Dr. Rod Bremner liderli\u011findeki bilim insanlar\u0131, mutasyon ta\u015f\u0131yan h\u00fccrelerin kanserle\u015fme potansiyelini belirleyen \u00f6nemli mekanizmalardan birinin h\u00fccrenin b\u00f6l\u00fcnme s\u00fcresi oldu\u011funu ke\u015ffettiler. Bu \u00e7al\u0131\u015fma, h\u00fccrelerin b\u00f6l\u00fcnme h\u0131z\u0131n\u0131n kanser diren\u00e7 mekanizmalar\u0131ndaki rol\u00fcn\u00fc geni\u015fleten ve kanser \u00f6nleme ile tedavi stratejileri i\u00e7in yeni ufuklar a\u00e7an \u00f6nemli bir bilimsel ilerleme niteli\u011fi ta\u015f\u0131yor.<\/p>\n
Kanser, h\u00fccrelerin kontrols\u00fcz bir \u015fekilde \u00e7o\u011falmas\u0131na yol a\u00e7an mutasyonlar\u0131n birikmesiyle olu\u015fur; ancak t\u00fcm mutasyonlu h\u00fccreler malign t\u00fcm\u00f6rlere d\u00f6n\u00fc\u015fmez. Bu durum, bilim d\u00fcnyas\u0131nda uzun zamand\u0131r merak konusu ve ara\u015ft\u0131rma alan\u0131d\u0131r. V\u00fccutta mutasyonlu h\u00fccreleri hedef alan ve yok eden apoptoz (programlanm\u0131\u015f h\u00fccre \u00f6l\u00fcm\u00fc) ve ba\u011f\u0131\u015f\u0131kl\u0131k sistemi gibi bir\u00e7ok savunma mekanizmas\u0131 bulunur. Dr. Bremner ve tak\u0131m\u0131n\u0131n yapt\u0131\u011f\u0131 \u00e7al\u0131\u015fma ise bu koruyucu mekanizmalara ek olarak h\u00fccre d\u00f6ng\u00fcs\u00fc s\u00fcresinin rol\u00fcn\u00fc vurgulamaktad\u0131r.<\/p>\n
Ara\u015ft\u0131rma ekibi, bir\u00e7ok preklinik model kullanarak ve retinoblastoma, hipofiz bezi t\u00fcm\u00f6rleri ile akci\u011fer karsinomlar\u0131 gibi farkl\u0131 kanser t\u00fcrlerinde h\u00fccre d\u00f6ng\u00fcs\u00fc s\u00fcresinin t\u00fcm\u00f6r olu\u015fumuna etkisini inceledi. Bulgular, mutasyonlu h\u00fccrelerin h\u0131zl\u0131 b\u00f6l\u00fcnenlerinin malign transformasyona daha yatk\u0131n oldu\u011funu, yava\u015f b\u00f6l\u00fcnen h\u00fccrelerin ise genellikle b\u00f6l\u00fcnme d\u00f6ng\u00fcs\u00fcn\u00fc sonland\u0131rarak sa\u011fl\u0131kl\u0131 h\u00fccre fenotiplerine d\u00f6nd\u00fc\u011f\u00fcn\u00fc ortaya koydu. Bu, h\u00fccre b\u00f6l\u00fcnme s\u00fcresinin kanser geli\u015fiminde belirleyici oldu\u011funu g\u00f6steren kapsaml\u0131 bir kan\u0131t olarak dikkat \u00e7ekti.<\/p>\n
Bu bulgu, kanser biyolojisi paradigmas\u0131n\u0131 de\u011fi\u015ftirme potansiyeline sahiptir. Dr. Bremner, mutasyonlu h\u00fccrelerin kanserle\u015fme s\u00fcrecinden \u201cka\u00e7mas\u0131n\u0131n\u201d temel nedeninin anormal b\u00f6l\u00fcnmeyi durdurarak normale d\u00f6nmeleri oldu\u011funu belirtti. Yani, uzun h\u00fccre d\u00f6ng\u00fcs\u00fc s\u00fcresine sahip h\u00fccreler, do\u011fal bir \u201cfren\u201d mekanizmas\u0131 gibi i\u015flev g\u00f6rerek kanserin ilerlemesini engelliyorlar. Bu mekanizma kanser diren\u00e7 sistemlerine ek, ba\u011f\u0131ms\u0131z ve etkili bir savunma hatt\u0131 olarak tan\u0131mland\u0131.<\/p>\n
Ara\u015ft\u0131rmada t\u00fcm\u00f6r bask\u0131lay\u0131c\u0131 mutasyonlar\u0131n i\u015flevsel hale getirildi\u011fi modellerde, kanser geli\u015fimini engelleyen y\u00f6ntemlerin hepsinde h\u00fccre d\u00f6ng\u00fcs\u00fcn\u00fcn uzad\u0131\u011f\u0131 g\u00f6zlendi. \u00d6zellikle retinoblastoma h\u00fccresinin, kanserle\u015fmeyen mutasyonlu h\u00fccrelere k\u0131yasla daha h\u0131zl\u0131 b\u00f6l\u00fcnd\u00fc\u011f\u00fcn\u00fcn saptanmas\u0131, h\u00fccre d\u00f6ng\u00fcs\u00fc kineti\u011fiyle kanser duyarl\u0131l\u0131\u011f\u0131 aras\u0131ndaki temel ili\u015fkiyi net \u015fekilde ortaya koydu. Bu durum, kanserin k\u00f6ken h\u00fccresinin tespiti i\u00e7in yeni biyobelirte\u00e7lerin geli\u015ftirilmesi a\u00e7\u0131s\u0131ndan \u00f6nemli bir temel olu\u015fturuyor.<\/p>\n
\u0130lgin\u00e7 olan bir di\u011fer bulgu, h\u00fccre d\u00f6ng\u00fcs\u00fcn\u00fcn yava\u015flat\u0131lmas\u0131n\u0131n apoptoz ya da ba\u011f\u0131\u015f\u0131kl\u0131k sistemine ba\u011fl\u0131 tipik diren\u00e7 mekanizmalar\u0131ndan ba\u011f\u0131ms\u0131z olarak kanser geli\u015fimini engellemesi oldu. Bu durum, h\u00fccre d\u00f6ng\u00fcs\u00fc s\u00fcresinin molek\u00fcler ve biyolojik olarak ayr\u0131 ve potansiyel olarak yeni bir tedavi hedefi oldu\u011funu g\u00f6sterdi. Ara\u015ft\u0131rman\u0131n farkl\u0131 doku tipleri ve kanser modellerinde tekrarland\u0131\u011f\u0131nda benzer sonu\u00e7lar vermesi, elde edilen verilerin geni\u015f bir ge\u00e7erlili\u011fi oldu\u011funu kan\u0131tlamaktad\u0131r.<\/p>\n
Cell cycle length yani h\u00fccre d\u00f6ng\u00fcs\u00fc s\u00fcresinin kanserin k\u00f6ken h\u00fccresini belirlemedeki \u00f6ng\u00f6r\u00fcc\u00fc rol\u00fc \u00e7arp\u0131c\u0131yd\u0131. T\u00fcm modellerde, t\u00fcm\u00f6r bask\u0131lay\u0131c\u0131 mutasyonlar\u0131n ne zaman ve hangi h\u00fccrelerde meydana geldi\u011fine bak\u0131lmaks\u0131z\u0131n, en k\u0131sa b\u00f6l\u00fcnme s\u00fcresine sahip mutasyonlu h\u00fccreler kanser geli\u015fimine neden oldu. Bu farkl\u0131 h\u00fccre alt k\u00fcmelerini tespit etmek, erken tan\u0131 ve risk gruplar\u0131n\u0131n belirlenmesi yolunda umut verici bir yakla\u015f\u0131m olarak \u00f6ne \u00e7\u0131k\u0131yor.<\/p>\n
Klinik a\u00e7\u0131dan bu bulgular, h\u00fccre d\u00f6ng\u00fcs\u00fcn\u00fcn modifiye edilebilir bir hedef olabilece\u011fi fikrini g\u00fc\u00e7lendiriyor. E\u011fer h\u00fccre b\u00f6l\u00fcnme h\u0131z\u0131n\u0131n kontrol alt\u0131na al\u0131nmas\u0131 m\u00fcmk\u00fcn olursa, \u00f6zellikle genetik yatk\u0131nl\u0131\u011f\u0131 olan bireylerde, mutasyon ta\u015f\u0131yan ama hen\u00fcz kansere d\u00f6n\u00fc\u015fmemi\u015f h\u00fccrelerin b\u00f6l\u00fcnmesi yava\u015flat\u0131larak kanserin \u00f6nlenmesi sa\u011flanabilir. Bu \u00f6nleyici stratejiler, kemoterapi ya da imm\u00fcnoterapi gibi klasik tedavilere alternatif veya tamamlay\u0131c\u0131 olabilir.<\/p>\n
H\u00fccre b\u00f6l\u00fcnme h\u0131z\u0131n\u0131n tedavi edilmesi fikri yeni olmamakla birlikte, bu \u00e7al\u0131\u015fma h\u00fccre d\u00f6ng\u00fcs\u00fc s\u00fcresinin onkolojik diren\u00e7teki benzersiz ve g\u00fc\u00e7l\u00fc rol\u00fcne ili\u015fkin deneysel d\u00fczeyde sa\u011flam kan\u0131tlar sunuyor. Dr. Bremner, farkl\u0131 h\u00fccre tiplerinde h\u00fccre d\u00f6ng\u00fcs\u00fcn\u00fc kontrol eden molek\u00fcler yollar\u0131n anla\u015f\u0131lmas\u0131n\u0131n, tedavi hedeflerini belirlemek a\u00e7\u0131s\u0131ndan kritik oldu\u011funu vurguluyor. \u00d6zellikle yaln\u0131zca kanser-prone mutasyonlu h\u00fccrelerin b\u00f6l\u00fcnme h\u0131z\u0131n\u0131 g\u00fcvenli ve etkili \u015fekilde yava\u015flatabilmek i\u00e7in molek\u00fcler mekanizmalar\u0131n detayl\u0131 ara\u015ft\u0131r\u0131lmas\u0131 gerekti\u011fini belirtiyor.<\/p>\n
Ara\u015ft\u0131rma, insan v\u00fccudunda milyonlarca mutasyon ta\u015f\u0131yan ancak kansere d\u00f6n\u00fc\u015fmeyen h\u00fccrelerin biyolojisini anlama konusunda da yeni kap\u0131lar aral\u0131yor. Say\u0131lar\u0131 trilyonlar\u0131 bulan bu h\u00fccreler, kanser direncine \u0131\u015f\u0131k tutabilecek zengin bir biyolojik kaynak olarak g\u00f6r\u00fcl\u00fcyor. Dr. Bremner ve ekibi, bu alanda yap\u0131lan \u00e7al\u0131\u015fmalar\u0131n hen\u00fcz ba\u015flang\u0131\u00e7 a\u015famas\u0131nda oldu\u011funun alt\u0131n\u0131 \u00e7izdi; ancak \u00f6n\u00fcm\u00fczdeki d\u00f6nemde bu h\u00fccrelerin incelenmesiyle hen\u00fcz ke\u015ffedilmemi\u015f koruyucu mekanizmalar\u0131n bulunabilece\u011fini vurguluyor.<\/p>\n
Ara\u015ft\u0131rman\u0131n y\u00fcr\u00fct\u00fclmesinde, Kanada Sa\u011fl\u0131k Ara\u015ft\u0131rmalar\u0131 Enstit\u00fcs\u00fc ile Krembil Vakf\u0131 deste\u011fi sa\u011flan\u0131rken, deneysel \u00e7al\u0131\u015fmalarda hayvan modelleri kritik rol oynad\u0131. Bilim insanlar\u0131ndan Dr. Danian Chen\u2019in \u00f6nemli katk\u0131lar\u0131yla, h\u00fccre d\u00f6ng\u00fcs\u00fc ve onkogenik transformasyon aras\u0131ndaki etkile\u015fimler kapsaml\u0131 bi\u00e7imde ara\u015ft\u0131r\u0131ld\u0131. Elde edilen veriler kanser geli\u015fimine dair h\u00fccresel d\u00fczeyde taze ve \u00f6zg\u00fcn bir perspektif sundu.<\/p>\n
Gelece\u011fe d\u00f6n\u00fck olarak bu \u00e7al\u0131\u015fma, kanser \u00f6nleme stratejilerinde h\u00fccre d\u00f6ng\u00fcs\u00fcn\u00fcn mod\u00fclasyonunu yeni bir hedef haline getirdi. Mevcut kanser tedavi yakla\u015f\u0131mlar\u0131n\u0131n \u00e7o\u011fu t\u00fcm\u00f6r olu\u015fumundan sonra uygulan\u0131rken, bu ara\u015ft\u0131rma erken a\u015fama d\u00f6n\u00fc\u015f\u00fcmleri yava\u015flatman\u0131n ya da durdurman\u0131n m\u00fcmk\u00fcn olabilece\u011fini g\u00f6steriyor. Proaktif ve hedefe y\u00f6nelik bu y\u00f6ntemler, \u00f6zellikle y\u00fcksek riskli hastalarda kanserin ba\u015flamadan engellenmesini sa\u011flayabilir.<\/p>\n
Sonu\u00e7 olarak, h\u00fccre d\u00f6ng\u00fcs\u00fc s\u00fcresinin kanser duyarl\u0131l\u0131\u011f\u0131nda hayati bir belirleyici oldu\u011fu ke\u015ffi, onkogenez anlay\u0131\u015f\u0131m\u0131zda devrim yarat\u0131yor. Hem temel biyolojik bilgimizi derinle\u015ftiriyor hem de kanseri yava\u015flatmak ya da \u00f6nlemek i\u00e7in yenilik\u00e7i m\u00fcdahale yollar\u0131 i\u00e7in umut do\u011furuyor. Dr. Bremner\u2019in de belirtti\u011fi gibi, kanserle\u015fmeyen h\u00fccrelerin dayan\u0131kl\u0131l\u0131\u011f\u0131ndan \u00f6\u011frenmek, modern t\u0131bb\u0131n kanseri yenmesinde \u00f6nemli bir d\u00f6n\u00fcm noktas\u0131 olabilir.<\/p>\n
—<\/p>\n
Ara\u015ft\u0131rma Konusu<\/strong>: Hayvan modelleri kullan\u0131larak h\u00fccre d\u00f6ng\u00fcs\u00fc s\u00fcresinin onkogenik d\u00f6n\u00fc\u015f\u00fcm kapasitesi \u00fczerindeki etkisi Kanser olu\u015fumunda kritik bir fakt\u00f6r olarak h\u00fccre d\u00f6ng\u00fcs\u00fc s\u00fcresi, Toronto\u2019daki Sinai Health\u2019e ba\u011fl\u0131 Lunenfeld-Tanenbaum Ara\u015ft\u0131rma Enstit\u00fcs\u00fc\u2019nde yap\u0131lan \u00e7\u0131\u011f\u0131r a\u00e7\u0131c\u0131 bir ara\u015ft\u0131rmada ortaya kondu. Dr. Rod Bremner liderli\u011findeki bilim insanlar\u0131, mutasyon ta\u015f\u0131yan h\u00fccrelerin kanserle\u015fme potansiyelini belirleyen \u00f6nemli mekanizmalardan birinin h\u00fccrenin b\u00f6l\u00fcnme s\u00fcresi oldu\u011funu ke\u015ffettiler. Bu \u00e7al\u0131\u015fma, h\u00fccrelerin b\u00f6l\u00fcnme h\u0131z\u0131n\u0131n kanser diren\u00e7 mekanizmalar\u0131ndaki rol\u00fcn\u00fc geni\u015fleten ve kanser…<\/p>\n","protected":false},"author":1,"featured_media":4394,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_yoast_wpseo_title":"","_yoast_wpseo_metadesc":"","_yoast_wpseo_focuskw":"","rank_math_title":"","rank_math_description":"","rank_math_focus_keyword":"","_wpan_schema_json_ld":"","_wpan_ai_seo_metadata":"","_wpan_ai_seo_status":"","_wpan_ai_seo_policy":"","_wpan_ai_seo_faq_block":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[28],"tags":[4479,4477,4480,4478,4481],"tmauthors":[],"class_list":{"0":"post-4393","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-kanser","8":"tag-hucre-bolunme-hizi-ve-kanser-duyarliligi","9":"tag-kanser-hucre-dongusu-suresi","10":"tag-kanser-tedavisinde-hucre-dongusu-hedefleri","11":"tag-mutasyonlu-hucrelerin-kanserlesme-mekanizmalari","12":"tag-retinoblastoma-ve-hucre-dongusu-iliskisi"},"jetpack_featured_media_url":"https:\/\/haber360.com\/wp-content\/uploads\/2025\/04\/Kanser-Icin-Hassas-Hucre-Tiplerinin-Yeni-Mekanizmalari-1746026975.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts\/4393","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/comments?post=4393"}],"version-history":[{"count":0,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts\/4393\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/media\/4394"}],"wp:attachment":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/media?parent=4393"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/categories?post=4393"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/tags?post=4393"},{"taxonomy":"tmauthors","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/tmauthors?post=4393"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nMakale Ba\u015fl\u0131\u011f\u0131<\/strong>: Cell cycle duration determines oncogenic transformation capacity
\nHaberin Yay\u0131n Tarihi<\/strong>: 30 Nisan 2025
\nWeb References<\/strong>: https:\/\/dx.doi.org\/10.1038\/s41586-025-08935-x
\nDoi Referans<\/strong>: 10.1038\/s41586-025-08935-x
\nAnahtar Kelimeler<\/strong>: Kanser ara\u015ft\u0131rmas\u0131, H\u00fccre d\u00f6ng\u00fcs\u00fc, H\u00fccre b\u00f6l\u00fcnme h\u0131z\u0131, Onkogenik potansiyel, Kanser diren\u00e7 mekanizmalar\u0131, Apoptoz, Ba\u011f\u0131\u015f\u0131kl\u0131k sistemi, Retinoblastoma, Akci\u011fer karsinomu, Hipofiz t\u00fcm\u00f6rleri, Kanser \u00f6nleme, H\u00fccre proliferasyon h\u0131z\u0131n\u0131n mod\u00fclasyonu<\/p>\n","protected":false},"excerpt":{"rendered":"